SARS-CoV-2 Omicron XBB.1 Variant Pseudovirus

SKU: orb1671374

Description

SARS-CoV-2 Omicron XBB.1 Variant Pseudovirus

Images & Validation

• Application Notes:
  Protocol: click here to download 1. Require BSL-2 or higher working environment 2. 5 μL per application (96-well plate) with at least 0.3 X 106 RLU / well. 3. Avoid freezing and thawing cycle to ensure the titer of the pseudovirus. 4. This product is for Research Use only5. Neutralization assay protocol is available

Key Properties

• Target: S

Storage & Handling

• Storage: The pseudovirus is stable in a liquid state at -70˚ for 12 months. Avoid repeated freeze-thaw cycles.
• Disclaimer: For research use only

Alternative Names

Spike glycoprotein Receptor-binding domain, S glycoprotein, Spike protein, Omicron variant spike, Omicron variant pseudovirus, Omicron, pseudovirus reporter, reporter virus particle

Neutralization Assay of Omicron XBB.1 and BQ.1.1 Variant Pseudoviruses by SARS-CoV-2 Spike Antibody, Neutralization antibodies: Anti-SARS-CoV-2 Spike antibodies, dilution: 2-2000 ng/mL. Pseudoviruses: SARS-CoV-2 Omicron XBB.1 (orb1671374) and BQ.1.1 (orb1671375) Spike Pseudoviruses. Infected Cells: ACE2-overexpressing 293T cells. Diluted antibody was incubated with Omicron XBB.1 or BQ.1.1 pseudoviruses at 37 °C for 1 hr. ACE2-overexpressing 293T cells were added in each well and incubated at 37 °C for 72 hrs. Luminescence reporter reagent was added in each well and the final results were read with the luminescence plate reader. Percent inhibition is calculated based on the RLU value.

Quick Database Links

Gene Symbol

S

UniProt

P0DTC1

RefSeq:QHD43416